Recent scientific research has found that inflammatory substances and cytokines in the brain of patients with depression are significantly higher. To put it simply, the brain is in a state of "fever". Imaging studies have also found that most patients with depression have poor blood flow and metabolism in the left prefrontal lobe, while the right side is overactivated. After scientific evidence that depression is related to the imbalance of cerebral cortex and nerve state, the medical community generally believes that "repetitive transcranial magnetic stimulation (rTMS) therapy" can provide a new treatment option for patients with depression.
What is "repetitive transcranial magnetic stimulation (rTMS) therapy"? Director Cai Mengzhao explained that this is a method of using magnetic coils to create continuous and regular repetitive electromagnetic pulses, so that the magnetic field reaches the industry email list cerebral cortex through the skull. It is a new type of treatment method that stimulates the disordered brain area rapidly and repeatedly through current changes, promotes blood circulation in the brain, and normally activates and inhibits metabolism and neural activity. In fact, this technology has been used in Europe and the United States for a long time.
Taiwan was approved by the Food and Drug Administration in 2018 and can be used for the treatment of severe depression, especially those with poor drug response and poor drug tolerance. Treatment-Refractory Depression,” as well as those with intolerable medication side effects and poor medication adherence. With the advancement of medical technology, the new generation of "Repetitive Transcranial Magnetic Stimulation System (Deep rTMS System)" escapes the traditional figure-8 coil design and adopts the patented deep stereotaxic helmet design combined with H-Coil. During the treatment, the coil can keep a closer fit with the head and provide a wider and deeper stimulation electric field, which is the latest weapon in psychiatric treatment.